Disciplines: Pharmacy
Hours: 12 Contact Hours
Item#: YPT12
Western Schools is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Sign up for the Western Schools 365 Online Membership

Psychiatric Medications Bundle


Reg. Prices
Just $73.95
Item # YPT12
New
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

This product includes the following courses:
Click on the title to see more and read the course

Anxiolytics and Traditional Mood Stabilizers

Price: $39.95 Hours:5 Contact Hours
Item # Y8011  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

The care of patients with mental health diagnoses is by no means limited to psychiatric facilities or practices. Due to the prevalence of mental illness in the U.S. population, patients taking psychiatric medications are treated in virtually all healthcare settings. Anxiety disorders, as a group, represent the most common form of psychiatric illness, and in turn, anti-anxiety medications are prescribed and dispensed with great frequency. Therefore, it is imperative that pharmacists maintain current knowledge of these common psychiatric illnesses and treatments.

This course is designed for pharmacists in all settings. The purpose of this course is to provide an overview of the psychiatric pharmacotherapy of anxiety disorders and bipolar disorder. This course provides the learner with essential information on anxiolytic and mood stabilizer medications. Clinical pharmacology and pharmacokinetics are briefly discussed in order to explain the actions of the drugs, their effects on symptoms, their most common side effects, and their most serious adverse reactions. Interactions with other medications and potential for abuse of some drugs are also presented. Learners should be able to apply the material from this course to patient management and teaching scenarios.

Universal Activity Number (UAN) - 0607-0000-16-009-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Antidepressants, 2nd Edition

Price: $25.95 Hours:3 Contact Hours
Item # Y8000  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

The purpose of this course is to provide current, evidence-based information for pharmacists (RPhs) on the mechanisms of action, pharmacokinetic and pharmacodynamics parameters, potential adverse events, adverse event management strategies, and special considerations affecting medication use and selection for medications used to treat depressive disorders. Although many medications used to treat depression have been around for several decades, new medications are constantly under development and it is important that healthcare professionals stay abreast of these new developments. In addition, the way that many of these medications with antidepressant properties are used in clinical practice continues to change. Although only some RPhs may specialize in mental health, all will encounter patients with mental health conditions such as major depressive disorder. This course is designed for RPhs practicing in all settings who may encounter patients taking antidepressants or be involved in initiating treatment with antidepressants.

Universal Activity Number (UAN) - 0607-0000-16-001-H01-P

Type of Activity - Knowledge

Topic Designator - 01– Disease State Management/Drug Therapy

Differentiating Antipsychotics: An Overview of Properties Impacting Drug Selection

Price: $32.95 Hours:4 Contact Hours
Item # Y8009  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

New antipsychotic agents are constantly under development, and the ways in which antipsychotic medications are used in clinical practice continue to change. As new information becomes available, there are new indications, safety warnings, monitoring recommendations, and dosage formulations. It is important that healthcare providers stay abreast of these new developments to optimize treatment. Due to the high rate of refractory schizophrenia, it is especially important for healthcare providers to be knowledgeable about new treatment options to offer to patients for whom previous treatments have failed and educate patients about potential benefits and adverse events. In addition, many antipsychotics have labeled indications for treatment of other mental illnesses, such as major depressive disorder and bipolar disorder, as well as many off-label uses.

The purpose of this course is to provide current, evidence-based information on the mechanisms of action, pharmacokinetic and pharmacodynamic parameters, adverse events, adverse event management strategies, clinical indications, and special considerations regarding antipsychotic use. This course is designed for pharmacists practicing in all settings who may encounter patients taking antipsychotic medications or be involved in initiating and/or monitoring treatment with antipsychotics.

Universal Activity Number (UAN) - 0607-0000-16-007-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy